Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2025-12-24 @ 11:38 PM
NCT ID:
NCT04633356
Eligibility Criteria:
Inclusion Criteria:
* Suffering from chronic hepatitis induced cirrhosis
* Informed consent available
Exclusion Criteria:
* Medical
* Child-Pugh Class C
* Uncorrected platelet count \<50,000
* INR \> 1.5 (natural)
* Anatomical
* Previous transjugular intrahepatic or surgical portosystemic shunt
* Portal vein thrombosis
* Anatomic alterations of the hepatic vasculature that prevent access to the portal vein or intrahepatic portion of the hepatic veins (identified at screening and/or during the endoscopic procedure).
* Previous history of spontaneous bacterial peritonitis within the previous three months
* Portopulmonary hypertension
* Cardiac decompensation
* Endoscopically Confirmed Exclusion Criteria
* Evidence of active GI bleeding (identified at screening and/or during the endoscopic procedure)
* If the volume of ascites in the path of the needle prevents apposition of the gastrointestinal tract and liver.
* Presence of gastric or duodenal ulcers, dieulafoy's lesion or cancers.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT04633356
Study Brief:
Protocol Section:
NCT04633356